GRI Bio GRI 深滬

已收盤 02-06 16:00:00 美东时间

2.39

+0.200

+9.13%

華盛通

立即下載

最高2.4999
今開2.23
成交量 15.94万股
最低 2.23
昨收 2.19
總市值 345.36万
52周最高 311.36
市盈率 ^靜 --
換手率 11.03%
52周最低 2.19
委比 0.74%
總股本 144.50万
歷史最高 64792072.80
量比 0.19
振幅 12.32%
歷史最低 2.23
每手 1
風險率 62.23%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

GRI Bio shares are trading higher. The company reported FY25 financial results.

GRI Bio shares are trading higher. The company reported FY25 financial results.

02-04 21:58
GRI Bio FY25 Net Loss $12M

GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of immune cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases today

02-04 21:56
GRI Bio raises $14.5 mln to fund operations into Q1 2027

GRI Bio raises $14.5 mln to fund operations into Q1 2027 Overview Biotechnology company raised $14.5 mln in gross proceeds to fund operations into Q1 2027 Company announced positive Phase 2a data for GRI-0621 in idiopathic pulmonary fibrosis Cash position expected to fund operations into Q1 2027 Out

02-04 21:56
BRIEF-GRI Bio May Offer Up To $250 Million In Securities - SEC Filing

BRIEF-GRI Bio May Offer Up To $250 Million In Securities - SEC Filing Jan 30 (Reuters) - GRI Bio Inc GRI.O : GRI BIO INC - MAY OFFER UP TO $250 MILLION IN SECURITIES - SEC FILING Source text: [ID:n0001824293-26-000028] Further company coverage: GRI.O (( Reuters.Briefs@thomsonreuters.com ;))

01-30 19:09
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Greenwich LifeSciences (NASDAQ:GLSI) shares rose 48.6% to $33.13 durin...

01-22 20:05
GRI Bio shares are trading lower after the company announced it approved a 1-for-28 reverse stock split.

GRI Bio shares are trading lower after the company announced it approved a 1-fo...

01-22 05:18
GRI Bio Shareholders Authorize Reverse Stock Split Plan

GRI Bio ( ($GRI) ) just unveiled an announcement. On January 15, 2026, GRI Bio,...

01-15 23:47
GRI Bio Expands At-The-Market Equity Offering Capacity

The latest announcement is out from GRI Bio ( ($GRI) ). On January 9, 2026, GRI...

01-09 21:59
12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 14.1% to...

01-09 05:06
GRI Bio Announced Cytometry Data From Phase 2a GRI-0621-IPF-02 Clinical Trial Evaluating GRI-0621 For Treatment Of Idiopathic Pulmonary Fibrosis

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung functionLA JOLLA, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc.

01-08 21:03

派息除權日	每股總股息	派息日期
2023-03-23	0.63	2023-03-28
2022-12-22	0.53	2022-12-29
2022-09-22	0.45	2022-09-29
2022-06-23	0.48	2022-06-30
2022-03-24	0.52	2022-03-31
2021-12-22	0.56	2021-12-29
2021-09-23	0.44	2021-09-30
2021-06-17	0.47	2021-06-24
2021-03-18	0.51	2021-03-25
2020-12-22	0.64	2020-12-30
2020-09-17	0.35	2020-09-24
2020-06-18	0.42	2020-06-25
2020-03-19	0.68	2020-03-26
2019-12-19	0.51	2019-12-27
2019-09-19	0.27	2019-09-26
2019-06-20	0.37	2019-06-27
2019-03-21	0.35	2019-03-28
2018-12-20	0.41	2018-12-27
2018-09-20	0.22	2018-09-27
2018-06-21	0.44	2018-06-28
2018-03-22	0.22	2018-03-29
2017-12-21	0.95	2017-12-28
2017-09-21	0.33	2017-09-27
2017-06-21	0.35	2017-06-28
2016-12-21	0.46	2016-12-29
2016-09-21	0.38	2016-09-28
2016-06-22	0.31	2016-06-29
2016-03-23	0.37	2016-03-31
2015-12-23	0.21	2015-12-31
2015-09-23	0.13	2015-09-30
2015-06-24	0.68	2015-07-01
2015-03-25	0.44	2015-04-01
2014-12-24	0.41	2015-01-02
2014-09-24	0.24	2014-10-01
2014-06-25	0.39	2014-07-02
2014-03-26	0.22	2014-04-02
2013-12-26	0.17	2014-01-03
2013-09-25	0.23	2013-10-02
2012-12-26	2.23	2013-01-03
2012-09-26	0.23	2012-10-03
2012-06-20	0.26	2012-06-27
2012-03-21	0.15	2012-03-28
2011-12-21	0.18	2011-12-28
2011-09-21	0.20	2011-09-28
2011-06-22	0.28	2011-06-29
2011-03-23	0.61	2011-03-30
2010-12-21	1.12	2010-12-29
2010-09-22	0.18	2010-09-29
2010-06-23	0.21	2010-06-30
2010-03-24	0.43	2010-03-31
2009-12-29	1.03	2010-01-06
2009-09-29	0.08	2009-10-06
2009-06-29	0.57	2009-07-07
2008-12-29	0.49	2009-01-05

公司名稱	GRI Bio
行業分類	--
業務描述	GRI Bio, Inc. engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded in May 2009 and is headquartered in La Jolla, CA.

GRI Bio GRI 深 滬

2.39

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

GRI Bio GRI 深滬